We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$164M
AUM Growth
+$4.83M
Cap. Flow
-$759K
Cap. Flow %
-0.46%
Top 10 Hldgs %
85.32%
Holding
58
New
4
Increased
8
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
VRML
Vermillion, Inc.
VRML
+$1.16M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.12M
3
DERM
Dermira, Inc.
DERM
+$1.08M
4
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$918K
5
BIIB icon
Biogen
BIIB
+$577K

Top Sells

Rank Stock Value
1
CMTA
Clementia Pharmaceuticals Inc.
CMTA
+$5.79M
2
IFRX icon
InflaRx
IFRX
+$605K
3
OMED
OncoMed Pharmaceuticals, Inc.
OMED
+$387K
4
CELG
Celgene Corp
CELG
+$128K
5
ATRA icon
Atara Biotherapeutics
ATRA
+$113K

Sector Composition

Rank Sector Weight
1 Healthcare 96.53%
2 Energy 1.97%
3 Consumer Staples 0.07%
4 Consumer Discretionary 0.05%
5 Materials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBIT icon
51
XBiotech
XBIT
$69.2M
$76K 0.05%
10,000
– –
WKHS icon
52
Workhorse Group
WKHS
$29.8M
$74K 0.05%
8
– –
LTHM
53
DELISTED
Livent Corporation
LTHM
$69K 0.04%
10,000
– –
GNMX
54
DELISTED
Aevi Genomic Medicine Inc
GNMX
$20K 0.01%
128,000
– –
IFRX icon
55
InflaRx
IFRX
$258M
– –
-16,000
Closed -$605K
SITO
56
DELISTED
SITO MOBILE, LTD
SITO
– –
-40,000
Closed -$73K
CMTA
57
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
– –
-222,000
Closed -$5.79M
OMED
58
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
– –
-372,557
Closed -$387K
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return
AF
Align Financial Hermantown, Minnesota $176M AUM
OA
Oceanside Advisors Mount Pleasant, South Carolina $175M AUM 17.96% 1-Year Est. Return

Birchview Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Birchview Capital held 58 positions worth $164M, up 3% from $160M the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Birchview Capital's Q2 2019 filing shows 4 new, 8 increased, 3 reduced and 4 closed positions. Its largest new stake was Acadia Pharmaceuticals: 10,000 shares worth $267K. The largest sale was Clementia Pharmaceuticals Inc., an estimated $5.79M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 97% a quarter earlier, followed by Energy and Consumer Staples.

  • Birchview Capital's largest Q2 2019 buy was Acadia Pharmaceuticals: 10,000 shares worth $267K.
  • Birchview Capital added most to Vermillion, Inc. in Q2 2019, an estimated $1.16M increase.
  • Birchview Capital's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $128K.
  • Birchview Capital fully exited Clementia Pharmaceuticals Inc. in Q2 2019, selling an estimated $5.79M.
  • Birchview Capital's ten largest holdings make up 85% of its $164M portfolio in Q2 2019.
  • Birchview Capital opened 4 new positions and closed 4 in Q2 2019.
  • Birchview Capital's portfolio value rose 3% quarter-over-quarter to $164M.

Based on Birchview Capital's 13F filing for Q2 2019, filed 6 Aug 2019.